Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Adamson

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Plos One|June 27, 2013
Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse modelIan Catchpole, Volker Germaschewski, Jaimie Hoh Kam, et al.
Cell Reports|June 14, 2016
T-bet Activates Th1 Genes through Mediator and the Super Elongation ComplexArnulf Hertweck, Catherine M Evans, Malihe Eskandarpour, et al.
The Lancet. Oncology|February 26, 2013
New policies to address the global burden of childhood cancersRichard Sullivan, Jerzy R Kowalczyk, Bharat Agarwal, et al.
Science Translational Medicine|April 4, 2014
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSarah L Doyle, Ema Ozaki, Kiva Brennan, et al.
American Journal of Human Genetics|March 13, 2018
Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated ToxicityChristina Zarouchlioti, Beatriz Sanchez-Pintado, Nathaniel J Hafford Tear, et al.
Molecular Therapy. Nucleic Acids|August 17, 2018
Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 ModelsKalyan Dulla, Monica Aguila, Amelia Lane, et al.
Facial Plastic Surgery & Aesthetic Medicine|February 4, 2026
Evolution of Facial Plastic Surgery Global Surgery Outreach in the Context of International Conflict and the COVID-19 PandemicChristie Hung, David Gorelov, Kiran Abraham-Aggarwal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2016
Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV modelPeter Adamson, Thomas Wilde, Eric Dobrzynski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutationsKalyan Dulla, Ralph Slijkerman, Hester C van Diepen, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Investigative Ophthalmology & Visual Science|February 7, 2013
Assessing a novel depot delivery strategy for noninvasive administration of VEGF/PDGF RTK inhibitors for ocular neovascular diseaseScott J Robbie, Peter Lundh von Leithner, Meihua Ju, et al.
Plos One|June 27, 2013
Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse modelIan Catchpole, Volker Germaschewski, Jaimie Hoh Kam, et al.
Cell Reports|June 14, 2016
T-bet Activates Th1 Genes through Mediator and the Super Elongation ComplexArnulf Hertweck, Catherine M Evans, Malihe Eskandarpour, et al.
The Lancet. Oncology|February 26, 2013
New policies to address the global burden of childhood cancersRichard Sullivan, Jerzy R Kowalczyk, Bharat Agarwal, et al.
Science Translational Medicine|April 4, 2014
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degenerationSarah L Doyle, Ema Ozaki, Kiva Brennan, et al.
American Journal of Human Genetics|March 13, 2018
Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated ToxicityChristina Zarouchlioti, Beatriz Sanchez-Pintado, Nathaniel J Hafford Tear, et al.
Molecular Therapy. Nucleic Acids|August 17, 2018
Splice-Modulating Oligonucleotide QR-110 Restores CEP290 mRNA and Function in Human c.2991+1655A>G LCA10 ModelsKalyan Dulla, Monica Aguila, Amelia Lane, et al.
Facial Plastic Surgery & Aesthetic Medicine|February 4, 2026
Evolution of Facial Plastic Surgery Global Surgery Outreach in the Context of International Conflict and the COVID-19 PandemicChristie Hung, David Gorelov, Kiran Abraham-Aggarwal, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 5, 2016
Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV modelPeter Adamson, Thomas Wilde, Eric Dobrzynski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2021
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutationsKalyan Dulla, Ralph Slijkerman, Hester C van Diepen, et al.
Pageof 8